BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Eastman Chemical Company (EMN) Announces Availability of Eastman Cellulose Acetate (CA-320S) for use as a Pharmaceutical Excipient in U.S and Europe


7/11/2008 11:08:07 AM

Kingsport, TN., (July 11, 2008) Eastman Chemical Company is pleased to announce the availability of Eastman™ Cellulose Acetate (CA-320S NF/EP), a pharmaceutical excipient for oral dosage drug formulations that enables improved delivery of active pharmaceutical ingredients.

Eastman™ CA-320S is an excipient that is particularly useful in controlled-release applications involving membrane release or matrix release. When used for controlled release applications, CA-320S aids in drug delivery by releasing the drug in the body at a controlled rate and over a predictable period of time.

CA-320S is the newest member of the Eastman family of cellulose esters for pharmaceutical applications including CA-398-10NF/EP, CAB 171-15 NF, and CA -320S NF/EP. Each has different physical properties and with the addition of CA-320S, formulators can have greater flexibility in designing drug delivery systems for targeted and controlled, sustained, or extended release.

CA-320S NF/EP is made under current good manufacturing conditions (cGMP) for oral dose pharmaceutical applications and meets the requirements of the National Formulary (NF) and European Pharmacopeia (EP).

About Eastman Chemical Company

Eastman manufactures and markets chemicals, fibers and plastics worldwide. It provides key differentiated coatings, adhesives and specialty plastics products; is a major supplier of cellulose acetate fibers; and produces PET polymers for packaging. As a Responsible Care® company, Eastman is committed to achieving the highest standards of health, safety, environmental and security performance. Founded in 1920 and headquartered in Kingsport, Tenn., Eastman is a FORTUNE 500 company with 2007 sales of $6.8 billion and approximately 10,500 employees.

For more information about Eastman and its products, visit www.eastman.com or contact Lucy Stewart, global trade media relations, at +1-423-229-4229 or globalmediarelations@eastman.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES